Stryker Corporation (LON:0R2S)
London
· Delayed Price · Currency is GBP · Price in USD 393.10
-1.30 (-0.33%)
At close: Jul 7, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Instruments | 2.83B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Instruments Growth | 9.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Endoscopy | 3.39B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Endoscopy Growth | 10.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical | 3.85B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Growth | 10.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Knees | 2.45B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Knees Growth | 8.85% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Hips | 1.70B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Hips Growth | 12.29% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Trauma and Extremities | 3.51B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Trauma and Extremities Growth | 12.91% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Spinal Implants | 707.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Spinal Implants Growth | 2.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Orthopaedics | 712.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Orthopaedics Growth | 2.37% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Neurovascular | 1.31B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Neurovascular Growth | 12.06% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Neuro Cranial | 2.14B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Neuro Cranial Growth | 15.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
MedSurg & Neurotechnology Operating Income | 4.00B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
MedSurg & Neurotechnology Operating Income Growth | 13.01% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Orthopaedics Operating Income | 2.59B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Orthopaedics Operating Income Growth | 18.01% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
United States | 16.94B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | 11.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
International | 5.65B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
International Growth | 8.39% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Organic Net Sales Growth | 10.20% |
Log In |
Log In |
Log In |
Log In | Upgrade
|